Guy Makin
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Cell death mechanisms and regulation 10
- Cancer therapeutics and mechanisms 7
- Protein Kinase Regulation and GTPase Signaling 4
- Neurology 17
- Neuroblastoma Research and Treatments 17
- Co-authors
- Caroline Dive (12 shared papers)John A. Hickman (1 shared paper)David Lohnes (1 shared paper)Glenville Jones (1 shared paper)Rebecca Ray (1 shared paper)Valarie Byford (1 shared paper)Muhammad H. Zaman (2 shared papers)Deema Hussein (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)British Journal of Cancer (4 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Guy Makin
47 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 330
- Oncology 480
- Neurology 243
- Pathology and Forensic Medicine 278
- Molecular Biology 903
Countries citing papers authored by Guy Makin
This map shows the geographic impact of Guy Makin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Makin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Makin more than expected).
Fields of papers citing papers by Guy Makin
This network shows the impact of papers produced by Guy Makin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Makin. The network helps show where Guy Makin may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Makin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 222 | |
| 2 | 2001 | 211 | |
| 3 | 2000 | 198 | |
| 4 | 2001 | 128 | |
| 5 | 2001 | 78 | |
| 6 | 2012 | 72 | |
| 7 | 2006 | 70 | |
| 8 | 1999 | 66 | |
| 9 | 2013 | 66 | |
| 10 | 2016 | 64 | |
| 11 | 2017 | 52 | |
| 12 | 2011 | 49 | |
| 13 | 2001 | 43 | |
| 14 | 2017 | 42 | |
| 15 | 2014 | 40 | |
| 16 | 2002 | 37 | |
| 17 | 2009 | 36 | |
| 18 | 2019 | 30 | |
| 19 | 2003 | 30 | |
| 20 | 2011 | 27 |
About Guy Makin
Guy Makin is a scholar working on Molecular Biology, Neurology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 49 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (17 papers), Cell death mechanisms and regulation (10 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer therapeutics and mechanisms (7 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), PARP inhibition in cancer therapy (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (330 citations), Oncology (480 citations), Neurology (243 citations), Pathology and Forensic Medicine (278 citations) and Molecular Biology (903 citations). Guy Makin has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Caroline Dive, John A. Hickman, David Lohnes, Glenville Jones, Rebecca Ray, Valarie Byford, Muhammad H. Zaman, Deema Hussein, Edward J. Estlin and Andrew Price. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Molecular Cancer Therapeutics, Clinical Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.